Solvay Pharmaceuticals
May 13, 2011 at 15:36 | Source: Moneycontrol.com
Apr 06, 2011 at 18:28 | Source: Moneycontrol.com
Feb 14, 2011 at 19:18 | Source: Moneycontrol.com
Feb 14, 2011 at 18:59 | Source: CNBC-TV18
Nov 24, 2010 at 14:38 | Source: Moneycontrol.com
Nov 01, 2010 at 15:13 | Source: Moneycontrol.com
Related News »
Solvay SA (Solvay) is a global chemical company, primarily operating in two sectors: chemicals and plastics. The chemicals sector specializes in high-purity fluorine, fluorinated gases, Barium Strontium, wet chemicals, soda ash, bicarbonate, caustic soda ...
May 19, 2012 at 15:49 | Source: Transworld News
On April 25, the U.S. Court of Appeals for the Eleventh Circuit affirmed a lower court's dismissal of the Federal Trade Commission's (FTC's) challenge to a patent settlement agreement between Solvay Pharmaceuticals and three generic competitors.
May 21, 2012 at 08:02 | Source: Mondaq
It employs some 29,000 people in 50 countries. In 2006, its consolidated sales amounted to EUR 9.4 billion, generated by its three sectors of activity: Chemicals, Plastics and Pharmaceuticals. Solvay (Euronext: SOLB.BE - Bloomberg: SOLB.BB - Reuters ...
May 17, 2012 at 12:17 | Source: ThomasNet Industrial News Room
Solvay S.A. is an international pharmaceuticals and chemicals group with headquarters in Brussels, Belgium, employing about 30,000 people in 50 countries. In 2003, its consolidated sales amounted to EUR 7.6 billion, generated by activities in its three ...
May 17, 2012 at 12:17 | Source: ThomasNet Industrial News Room
Stephen McDonald has received speaking honoraria from AMGEN Australia, Fresenius Australia and Solvay Pharmaceuticals and travel grants from AMGEN Australia, Genzyme Australia and Jansen-Cilag. The remaining authors have no competing financial interests to declare.
May 24, 2012 at 21:05 | Source: EurekAlert
Prior to his position at GTx, Barnette served as the Director of Regulatory Affairs for Solvay Pharmaceuticals in Marietta, Ga., and for the FDA office of Clinical Pharmacology and Biopharmaceutics as a reviewer of more than 50 NDA and sNDA ...
May 22, 2012 at 12:11 | Source: Genetic Engineering News
associated with the acquisition of Solvay Pharmaceuticals and $78 million, or 5 cents per share, for previously announced cost reduction initiatives and other. These items were partially offset by a favorable adjustment to tax expense of $51 ...
May 17, 2012 at 13:57 | Source: Investorplace.com
JCR Pharmaceuticals Co., Ltd.; and Solvay Pharmaceuticals BV, as well as a strategic alliance with Uman Pharma. The company was formerly known as Medi-Ject Corporation and changed its name to Antares Pharma, Inc. in January 2001. Antares Pharma ...
May 18, 2012 at 16:19 | Source: TMCnet